Skip to main content
Top
Published in: Rheumatology International 2/2014

01-02-2014 | Letter to the Editor

Searching for optimal rating scales in the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

Authors: Franco Franchignoni, Fausto Salaffi, Alessandro Ciapetti, Andrea Giordano

Published in: Rheumatology International | Issue 2/2014

Login to get access

Abstract

The comparison of the performance of the numerical rating scale (NRS) versus visual analog scale (VAS) in the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) showed that the 11-point NRS is psychometrically superior to the 10-cm VAS. This finding is in agreement with previous studies and the recommendation by the Assessment of SpondyloArthritis international Society. To illustrate the functioning of the response categories of both BASFI and BASDAI, we analyzed the rating scales (using the Rasch rating scale model) in patients with ankylosing spondylitis. Our results have shown that the 11 categories available in the 0–10 NRS version of both BASFI and BASDAI exceed the number of levels of a construct that participants can discriminate. This indicates the need for improving the metric quality of both rating scales by appropriately reducing the number of categories.
Literature
1.
go back to reference Akad K, Solmaz D, Sari I, Onen F, Akkoc N, Akar S (2013) Performance of response scales of activity and functional measures of ankylosing spondylitis: numerical rating scale versus visual analog scale. Rheumatol Int 33:2617–2623PubMedCrossRef Akad K, Solmaz D, Sari I, Onen F, Akkoc N, Akar S (2013) Performance of response scales of activity and functional measures of ankylosing spondylitis: numerical rating scale versus visual analog scale. Rheumatol Int 33:2617–2623PubMedCrossRef
2.
go back to reference Van Tubergen A, Debats I, Ryser L, Londono J, Burgos-Vargas R, Cardiel MH et al (2002) Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. Arthritis Rheum 47:242–248PubMedCrossRef Van Tubergen A, Debats I, Ryser L, Londono J, Burgos-Vargas R, Cardiel MH et al (2002) Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. Arthritis Rheum 47:242–248PubMedCrossRef
3.
go back to reference Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–ii44PubMedCrossRef Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–ii44PubMedCrossRef
4.
go back to reference Franchignoni F, Salaffi F, Tesio L (2012) How should we use the visual analogue scale (VAS) in rehabilitation outcomes? I: how much of what? The seductive VAS numbers are not true measures. J Rehabil Med 44:798–799PubMedCrossRef Franchignoni F, Salaffi F, Tesio L (2012) How should we use the visual analogue scale (VAS) in rehabilitation outcomes? I: how much of what? The seductive VAS numbers are not true measures. J Rehabil Med 44:798–799PubMedCrossRef
5.
go back to reference Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use, 4th edn. Oxford University Press, Oxford, pp 41–55CrossRef Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use, 4th edn. Oxford University Press, Oxford, pp 41–55CrossRef
6.
go back to reference Wolfe EW, Smith EV Jr (2007) Instrument development tools and activities for measure validation using Rasch models: part I. J Appl Meas 8:97–123PubMed Wolfe EW, Smith EV Jr (2007) Instrument development tools and activities for measure validation using Rasch models: part I. J Appl Meas 8:97–123PubMed
7.
go back to reference Khadka J, Gothwal VK, McAlinden C, Lamoureux EL, Pesudovs K (2012) The importance of rating scales in measuring patient-reported outcomes. Health Qual Life Outcomes 10:80PubMedCentralPubMedCrossRef Khadka J, Gothwal VK, McAlinden C, Lamoureux EL, Pesudovs K (2012) The importance of rating scales in measuring patient-reported outcomes. Health Qual Life Outcomes 10:80PubMedCentralPubMedCrossRef
8.
go back to reference Eyres S, Tennant A, Kay L, Waxman R, Helliwell PS (2002) Measuring disability in ankylosing spondylitis: comparison of Bath Ankylosing Spondylitis Functional Index with revised Leeds Disability Questionnaire. J Rheumatol 29:979–986PubMed Eyres S, Tennant A, Kay L, Waxman R, Helliwell PS (2002) Measuring disability in ankylosing spondylitis: comparison of Bath Ankylosing Spondylitis Functional Index with revised Leeds Disability Questionnaire. J Rheumatol 29:979–986PubMed
9.
go back to reference Leung YY, Tam LS, Kun EW, Ho KW, Li EK (2008) Comparison of 4 functional indexes in psoriatic arthritis with axial or peripheral disease subgroups using Rasch analyses. J Rheumatol 35:1613–1621PubMed Leung YY, Tam LS, Kun EW, Ho KW, Li EK (2008) Comparison of 4 functional indexes in psoriatic arthritis with axial or peripheral disease subgroups using Rasch analyses. J Rheumatol 35:1613–1621PubMed
10.
go back to reference Salaffi F, Franchignoni F, Giordano A, Ciapetti A, Sarzi Puttini P, Ottonello M (2013) Psychometric characteristics of the Italian version of the revised Fibromyalgia Impact Questionnaire using classical test theory and Rasch analysis. Clin Exp Rheumatol Jun 26 (Epub ahead of print) Salaffi F, Franchignoni F, Giordano A, Ciapetti A, Sarzi Puttini P, Ottonello M (2013) Psychometric characteristics of the Italian version of the revised Fibromyalgia Impact Questionnaire using classical test theory and Rasch analysis. Clin Exp Rheumatol Jun 26 (Epub ahead of print)
Metadata
Title
Searching for optimal rating scales in the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
Authors
Franco Franchignoni
Fausto Salaffi
Alessandro Ciapetti
Andrea Giordano
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 2/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2891-0

Other articles of this Issue 2/2014

Rheumatology International 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.